ResearcherInstitut Gustave RoussyActive in the last 2 years

Roland Eid

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1097-2594; OpenAlex author ID A5010537164. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. Co-author DOI 10.1080/14796694.2025.2461442 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Anthony Tarabay · 1 shared paper, 2025 · strength 0.19
- Paper Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. DOI 10.1080/14796694.2025.2461442 ↗
Cristina Smolenschi · 1 shared paper, 2025 · strength 0.19
- Paper Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. DOI 10.1080/14796694.2025.2461442 ↗
Antoine Hollebecque · 1 shared paper, 2025 · strength 0.19
- Paper Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. DOI 10.1080/14796694.2025.2461442 ↗
Michel Pierre Ducreux · 1 shared paper, 2025 · strength 0.19
- Paper Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. DOI 10.1080/14796694.2025.2461442 ↗
Nathalie Lassau · 1 shared paper, 2025 · strength 0.19
- Paper Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. DOI 10.1080/14796694.2025.2461442 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.